tetano
Editor, Senior Moderator
Postepy Dermatol Alergol
. 2021 Dec;38(6):943-947.
doi: 10.5114/ada.2020.95958. Epub 2020 Jul 23.
Cutaneous manifestations of coronavirus disease 2019 - review of literature and case reports
Piotr Ciechanowicz[SUP] 1 [/SUP], Elżbieta Szymańska[SUP] 1 [/SUP], Kacper Wiszniewski[SUP] 2 [/SUP], Irena Walecka[SUP] 1 [/SUP]
Affiliations
Abstract
Primary clinical manifestations of coronavirus disease are respiratory tract infections, ranging from an asymptomatic carrier state to severe interstitial pneumonia. The most common symptoms are fever, dry cough, fatigue, nausea, diarrhea, and loss of smell or taste. Recent reports indicate the possibility of several nonspecific dermatological symptoms. These include urticaria, maculopapular lesions, vascular lesions involving petechiae, purpura and livedo reticularis. The onset of cutaneous lesions may precede full-blown COVID-19 or remain the only manifestation of the disease (especially in young patients). Focusing on dermatological symptoms may be crucial for preventing the spread of SARS-CoV-2. However, unambiguous assessment of cutaneous manifestations of COVID-19 requires more research and case studies conducted by dermatologists.
Keywords: COVID-19; SARS-CoV-2; coronavirus; cutaneous manifestations; pseudo-chilblain; skin manifestations.
. 2021 Dec;38(6):943-947.
doi: 10.5114/ada.2020.95958. Epub 2020 Jul 23.
Cutaneous manifestations of coronavirus disease 2019 - review of literature and case reports
Piotr Ciechanowicz[SUP] 1 [/SUP], Elżbieta Szymańska[SUP] 1 [/SUP], Kacper Wiszniewski[SUP] 2 [/SUP], Irena Walecka[SUP] 1 [/SUP]
Affiliations
- PMID: 35125998
- PMCID: PMC8802969
- DOI: 10.5114/ada.2020.95958
Abstract
Primary clinical manifestations of coronavirus disease are respiratory tract infections, ranging from an asymptomatic carrier state to severe interstitial pneumonia. The most common symptoms are fever, dry cough, fatigue, nausea, diarrhea, and loss of smell or taste. Recent reports indicate the possibility of several nonspecific dermatological symptoms. These include urticaria, maculopapular lesions, vascular lesions involving petechiae, purpura and livedo reticularis. The onset of cutaneous lesions may precede full-blown COVID-19 or remain the only manifestation of the disease (especially in young patients). Focusing on dermatological symptoms may be crucial for preventing the spread of SARS-CoV-2. However, unambiguous assessment of cutaneous manifestations of COVID-19 requires more research and case studies conducted by dermatologists.
Keywords: COVID-19; SARS-CoV-2; coronavirus; cutaneous manifestations; pseudo-chilblain; skin manifestations.